2013 first-quarter revenues
Bezons, April 24th, 2013 - 5:45pm - RIBER, the global leader for molecular beam epitaxy (MBE), recorded €2.7 million in revenues for the first quarter of 2013, compared with €6.2 million for the first quarter of 2012. At the end of March 2013, the order book represented €14.6 million.
| At March 31st (€'000,000) | 2013 | 2012 | Change |
| Systems | 0.9 | 4.6 | -80% |
| Services and accessories | 1.4 | 1.0 | +35% |
| Cells and sources | 0.4 | 0.6 | -33% |
| Total reported revenues | 2.7 | 6.2 | -56% |
| Systems order book | 13.4 | 17.9 | -25% |
| Services and accessories order book | 1.1 | 1.5 | -28% |
| Cells and sources order book | 0.1 | 0.1 | +12% |
| Total order book | 14.6 | 19.5 | -25% |
Business developments
RIBER delivered one research machine during the first quarter of 2013, compared with three research machines and one production machine for the same period in 2012. In this context, machine sales came to €0.9 million at March 31st, 2013, compared with €4.6 million at March 31st, 2012. First-quarter revenues are dependent on the production cycle for systems that have been ordered and are not an indication of the company's performance over the full year.
The MBE services and accessories business has confirmed its turnaround, following work to further strengthen the commercial and technical organization. Revenues are up 35% in relation to the first quarter of 2012.
Sales of evaporation sources and cells are not particularly significant in view of the low level of investments in the OLED and photovoltaic sectors. To prepare for the next waves of investments, RIBER is maintaining a major research effort on these structurally buoyant markets.
Outlook
During the period, RIBER booked three MBE system orders for research laboratories in China, Russia and India. At March 31st, 2013, the order book represented €14.6 million (€12.1 million at end-2012), with 14 research systems to be delivered in 2013.
Next date: General Meeting on Friday May 31st, 2013
About RIBER:
Riber designs and produces molecular beam epitaxy (MBE) systems as well as evaporation sources and cells for the semiconductor industry. This high-technology equipment is essential for the manufacturing of compound semiconductor materials and new materials that are used in numerous consumer applications, such as new information technologies, OLED flat screens and new generation solar cells.
Riber recorded €27.4 million in revenues in 2012 and employs 111 people. The company is ISO9001 certified.
Riber is listed on NYSE-Euronext Paris, Compartment "C", and is part of the CAC Small, CAC Mid & Small, CAC Technology and CAC T. HARD & EQ indices.
Riber is one of the best-rated companies in the Gaïa-index, the leading SRI index for French mid-caps.
ISIN: FR0000075954 - RIB
Reuters: RIBE.PA
Bloomberg: RIB: FP
OSEO-approved innovative company
| RIBER Olivier Handschumacher tel: +33 1 39 96 65 00 invest@riber.com | CALYPTUS Cyril Combe tel: +33 1 53 65 68 68 cyril.combe@calyptus.net |
